SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-003257
Filing Date
2020-03-27
Accepted
2020-03-27 16:16:38
Documents
73
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apre-20191231x10k.htm 10-K 3056881
2 EX-4.1 apre-20191231ex411748a61.htm EX-4.1 19145
3 EX-23.1 apre-20191231ex23114ca68.htm EX-23.1 2785
4 EX-23.2 apre-20191231ex232b33367.htm EX-23.2 2455
5 EX-31.1 apre-20191231ex31103f4ed.htm EX-31.1 24018
6 EX-31.2 apre-20191231ex312f518f1.htm EX-31.2 23628
7 EX-32.1 apre-20191231ex321edf5be.htm EX-32.1 6958
8 EX-32.2 apre-20191231ex3226af9ab.htm EX-32.2 6760
9 GRAPHIC apre20191231x10k001.jpg GRAPHIC 57628
10 GRAPHIC apre20191231x10k002.jpg GRAPHIC 9768
11 GRAPHIC apre20191231x10k003.jpg GRAPHIC 15336
12 GRAPHIC apre20191231x10k004.jpg GRAPHIC 27371
13 GRAPHIC apre20191231x10k005.jpg GRAPHIC 27150
14 GRAPHIC apre20191231x10k006.jpg GRAPHIC 19013
15 GRAPHIC apre20191231x10k007.jpg GRAPHIC 28430
16 GRAPHIC apre20191231x10k008.jpg GRAPHIC 17484
17 GRAPHIC apre20191231x10k009.jpg GRAPHIC 24118
  Complete submission text file 0001558370-20-003257.txt   7402814

Data Files

Seq Description Document Type Size
18 EX-101.INS apre-20191231.xml EX-101.INS 1051610
19 EX-101.SCH apre-20191231.xsd EX-101.SCH 39059
20 EX-101.CAL apre-20191231_cal.xml EX-101.CAL 44381
21 EX-101.DEF apre-20191231_def.xml EX-101.DEF 154757
22 EX-101.LAB apre-20191231_lab.xml EX-101.LAB 398128
23 EX-101.PRE apre-20191231_pre.xml EX-101.PRE 289261
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39069 | Film No.: 20752005
SIC: 2834 Pharmaceutical Preparations